Your browser doesn't support javascript.
loading
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
George, Thomas J; Franke, Aaron J; Chakravarthy, A Bapsi; Das, Prajnan; Dasari, Arvind; El-Rayes, Bassel F; Hong, Theodore S; Kinsella, Timothy J; Landry, Jerome C; Lee, James J; Monjazeb, Arta M; Jacobs, Samuel A; Raben, David; Rahma, Osama E; Williams, Terence M; Wu, Christina; Coleman, C Norman; Vikram, Bhadrasain; Ahmed, Mansoor M.
Afiliación
  • George TJ; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.
  • Franke AJ; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.
  • Chakravarthy AB; Department of Radiation Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Das P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • El-Rayes BF; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard, Boston, Massachusetts.
  • Kinsella TJ; Department of Radiation Oncology, Rhode Island Hospital-Brown University Alpert Medical School, Providence, Rhode Island.
  • Landry JC; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Lee JJ; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Monjazeb AM; Division of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Jacobs SA; National Adjuvant Surgical and Bowel Project Foundation/NRG Oncology, Pittsburg, Pennsylvania.
  • Raben D; Department of Radiation Oncology, University of Colorado Denver School of Medicine, Aurora, Colorado.
  • Rahma OE; Center for Immuno-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Williams TM; Department of Radiation Oncology, The Ohio State University, Columbus, Ohio.
  • Wu C; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Coleman CN; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Vikram B; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Ahmed MM; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer ; 125(16): 2732-2746, 2019 08 15.
Article en En | MEDLINE | ID: mdl-31017664
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Neoplasias Colorrectales Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Neoplasias Colorrectales Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article